Evidence map›Paper›PMID 35347047›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2022

Changes in ischemic stroke presentations, management and outcomes during the first year of the COVID-19 pandemic in Alberta: a population study.

Aravind Ganesh, Jillian M Stang, Finlay A McAlister, Oleksandr Shlakhter, Jessalyn K Holodinsky, Balraj Mann, Michael D Hill, Eric E Smith

Abstract read
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Application of radiomics in ischemic stroke.The Journal of international medical research · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Death as a metric for outcome: Dusk between day and night.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2022
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aravind GaneshCalgary Stroke Program, Department of Clinical Neurosciences (Ganesh, Holodinsky, Hill, Smith); Departments of Radiology, and of Community Health Sciences (Ganesh, Hill, Smith), Cumming School of Medicine, University of Calgary; Hotchkiss Brain Institute (Ganesh, Hill, Smith); Foothills Medical Centre (Ganesh, Holodinsky, Hill, Smith), Alberta Health Services, Calgary, Alta.; Alberta Health Services (Stang), Red Deer, Alta.; Division of General Internal Medicine, Faculty of Medicine and Dentistry (McAlister), University of Alberta; Alberta Health Services (Shlakhter, Mann); Cardiovascular Health and Stroke Strategic Clinical Network (Mann), Alberta Health Services, Edmonton, Alta.; Department of Medicine (Hill), Cumming School of Medicine, University of Calgary, Calgary, Alta.
Jillian M StangCalgary Stroke Program, Department of Clinical Neurosciences (Ganesh, Holodinsky, Hill, Smith); Departments of Radiology, and of Community Health Sciences (Ganesh, Hill, Smith), Cumming School of Medicine, University of Calgary; Hotchkiss Brain Institute (Ganesh, Hill, Smith); Foothills Medical Centre (Ganesh, Holodinsky, Hill, Smith), Alberta Health Services, Calgary, Alta.; Alberta Health Services (Stang), Red Deer, Alta.; Division of General Internal Medicine, Faculty of Medicine and Dentistry (McAlister), University of Alberta; Alberta Health Services (Shlakhter, Mann); Cardiovascular Health and Stroke Strategic Clinical Network (Mann), Alberta Health Services, Edmonton, Alta.; Department of Medicine (Hill), Cumming School of Medicine, University of Calgary, Calgary, Alta.
Finlay A McAlisterCalgary Stroke Program, Department of Clinical Neurosciences (Ganesh, Holodinsky, Hill, Smith); Departments of Radiology, and of Community Health Sciences (Ganesh, Hill, Smith), Cumming School of Medicine, University of Calgary; Hotchkiss Brain Institute (Ganesh, Hill, Smith); Foothills Medical Centre (Ganesh, Holodinsky, Hill, Smith), Alberta Health Services, Calgary, Alta.; Alberta Health Services (Stang), Red Deer, Alta.; Division of General Internal Medicine, Faculty of Medicine and Dentistry (McAlister), University of Alberta; Alberta Health Services (Shlakhter, Mann); Cardiovascular Health and Stroke Strategic Clinical Network (Mann), Alberta Health Services, Edmonton, Alta.; Department of Medicine (Hill), Cumming School of Medicine, University of Calgary, Calgary, Alta.
Oleksandr ShlakhterCalgary Stroke Program, Department of Clinical Neurosciences (Ganesh, Holodinsky, Hill, Smith); Departments of Radiology, and of Community Health Sciences (Ganesh, Hill, Smith), Cumming School of Medicine, University of Calgary; Hotchkiss Brain Institute (Ganesh, Hill, Smith); Foothills Medical Centre (Ganesh, Holodinsky, Hill, Smith), Alberta Health Services, Calgary, Alta.; Alberta Health Services (Stang), Red Deer, Alta.; Division of General Internal Medicine, Faculty of Medicine and Dentistry (McAlister), University of Alberta; Alberta Health Services (Shlakhter, Mann); Cardiovascular Health and Stroke Strategic Clinical Network (Mann), Alberta Health Services, Edmonton, Alta.; Department of Medicine (Hill), Cumming School of Medicine, University of Calgary, Calgary, Alta.
Jessalyn K HolodinskyCalgary Stroke Program, Department of Clinical Neurosciences (Ganesh, Holodinsky, Hill, Smith); Departments of Radiology, and of Community Health Sciences (Ganesh, Hill, Smith), Cumming School of Medicine, University of Calgary; Hotchkiss Brain Institute (Ganesh, Hill, Smith); Foothills Medical Centre (Ganesh, Holodinsky, Hill, Smith), Alberta Health Services, Calgary, Alta.; Alberta Health Services (Stang), Red Deer, Alta.; Division of General Internal Medicine, Faculty of Medicine and Dentistry (McAlister), University of Alberta; Alberta Health Services (Shlakhter, Mann); Cardiovascular Health and Stroke Strategic Clinical Network (Mann), Alberta Health Services, Edmonton, Alta.; Department of Medicine (Hill), Cumming School of Medicine, University of Calgary, Calgary, Alta.
Balraj MannCalgary Stroke Program, Department of Clinical Neurosciences (Ganesh, Holodinsky, Hill, Smith); Departments of Radiology, and of Community Health Sciences (Ganesh, Hill, Smith), Cumming School of Medicine, University of Calgary; Hotchkiss Brain Institute (Ganesh, Hill, Smith); Foothills Medical Centre (Ganesh, Holodinsky, Hill, Smith), Alberta Health Services, Calgary, Alta.; Alberta Health Services (Stang), Red Deer, Alta.; Division of General Internal Medicine, Faculty of Medicine and Dentistry (McAlister), University of Alberta; Alberta Health Services (Shlakhter, Mann); Cardiovascular Health and Stroke Strategic Clinical Network (Mann), Alberta Health Services, Edmonton, Alta.; Department of Medicine (Hill), Cumming School of Medicine, University of Calgary, Calgary, Alta.
Michael D HillCalgary Stroke Program, Department of Clinical Neurosciences (Ganesh, Holodinsky, Hill, Smith); Departments of Radiology, and of Community Health Sciences (Ganesh, Hill, Smith), Cumming School of Medicine, University of Calgary; Hotchkiss Brain Institute (Ganesh, Hill, Smith); Foothills Medical Centre (Ganesh, Holodinsky, Hill, Smith), Alberta Health Services, Calgary, Alta.; Alberta Health Services (Stang), Red Deer, Alta.; Division of General Internal Medicine, Faculty of Medicine and Dentistry (McAlister), University of Alberta; Alberta Health Services (Shlakhter, Mann); Cardiovascular Health and Stroke Strategic Clinical Network (Mann), Alberta Health Services, Edmonton, Alta.; Department of Medicine (Hill), Cumming School of Medicine, University of Calgary, Calgary, Alta.
Eric E SmithCalgary Stroke Program, Department of Clinical Neurosciences (Ganesh, Holodinsky, Hill, Smith); Departments of Radiology, and of Community Health Sciences (Ganesh, Hill, Smith), Cumming School of Medicine, University of Calgary; Hotchkiss Brain Institute (Ganesh, Hill, Smith); Foothills Medical Centre (Ganesh, Holodinsky, Hill, Smith), Alberta Health Services, Calgary, Alta.; Alberta Health Services (Stang), Red Deer, Alta.; Division of General Internal Medicine, Faculty of Medicine and Dentistry (McAlister), University of Alberta; Alberta Health Services (Shlakhter, Mann); Cardiovascular Health and Stroke Strategic Clinical Network (Mann), Alberta Health Services, Edmonton, Alta.; Department of Medicine (Hill), Cumming School of Medicine, University of Calgary, Calgary, Alta.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPandemics may promote hospital avoidance, and added precautions may exacerbate treatment delays for medical emergencies such as stroke. We sought to evaluate ischemic stroke presentations, management and outcomes during the first year of the COVID-19 pandemic.

methodsWe conducted a population-based study, using linked administrative and stroke registry data from Alberta to identify all patients presenting with stroke before the pandemic (Jan. 1, 2016 to Feb. 27, 2020) and in 5 periods over the first pandemic year (Feb. 28, 2020 to Mar. 31, 2021), reflecting changes in case numbers and restrictions. We evaluated changes in hospital admissions, emergency department presentations, thrombolysis, endovascular therapy, workflow times and outcomes.

resultsThe study included 19 531 patients in the prepandemic period and 4900 patients across the 5 pandemic periods. Presentations for ischemic stroke dropped in the first pandemic wave (weekly adjusted incidence rate ratio [IRR] 0.54, 95% confidence interval [CI] 0.50 to 0.59). Population-level incidence of thrombolysis (adjusted IRR 0.50, 95% CI 0.41 to 0.62) and endovascular therapy (adjusted IRR 0.63, 95% CI 0.47 to 0.84) also decreased during the first wave, but proportions of patients presenting with stroke who received acute therapies did not decline. Rates of patients presenting with stroke did not return to prepandemic levels, even during a lull in COVID-19 cases between the first 2 waves of the pandemic, and fell further in subsequent waves. In-hospital delays in thrombolysis or endovascular therapy occurred in several pandemic periods. The likelihood of in-hospital death increased in Wave 2 (adjusted odds ratio [OR] 1.48, 95% CI 1.25 to 1.74) and Wave 3 (adjusted OR 1.46, 95% CI 1.07 to 2.00). Out-of-hospital deaths, as a proportion of stroke-related deaths, rose during 4 of 5 pandemic periods.

interpretationThe first year of the COVID-19 pandemic saw persistently reduced rates of patients presenting with ischemic stroke, recurrent treatment delays and higher risk of in-hospital death in later waves. These findings support public health messaging that encourages care-seeking for medical emergencies during pandemic periods, and stroke systems should re-evaluate protocols to mitigate inefficiencies.

Indexed as

COVID-19Ischemic StrokeAlbertaHospital MortalityHumansPandemics

Identifiers

PMID35347047
PMCPMC8967441

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.